Parametric Portfolio Associates’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $5.69M | Sell |
|
|||||
|
2021
Q4 | $6.75M | Buy |
|
|||||
|
2021
Q3 | $4.46M | Buy |
|
|||||
|
2021
Q2 | $2.72M | Sell |
|
|||||
|
2021
Q1 | $5.25M | Buy |
|
|||||
|
2020
Q4 | $2.13M | Buy |
|
|||||
|
2020
Q3 | $2.19M | Buy |
|
|||||
|
2020
Q2 | $1.8M | Sell |
|
|||||
|
2020
Q1 | $1.86M | Buy |
|
|||||
|
2019
Q4 | $1.64M | Sell |
|
|||||
|
2019
Q3 | $1.8M | Buy |
|
|||||
|
2019
Q2 | $2.49M | Sell |
|
|||||
|
2019
Q1 | $3.06M | Sell |
|
|||||
|
2018
Q4 | $2.49M | Buy |
|
|||||
|
2018
Q3 | $2.51M | Sell |
|
|||||
|
2018
Q2 | $4.79M | Buy |
|
|||||
|
2018
Q1 | $2.59M | Buy |
|
|||||
|
2017
Q4 | $1.4M | Buy |
|
|||||
|
2017
Q3 | $778K | Buy |
|
|||||
|
2017
Q2 | $460K | Buy |
|
|||||
|
2017
Q1 | $365K | Buy |
|
|||||
|
2016
Q4 | $330K | Sell |
|
|||||
|
2016
Q3 | $309K | Sell |
|
|||||
|
2016
Q2 | $357K | Sell |
|
|||||
|
2016
Q1 | $672K | Buy |
|
|||||
|
2015
Q4 | $570K | Buy |
|
|||||
|
2015
Q3 | $611K | Sell |
|
|||||
|
2015
Q2 | $864K | Buy |
|
|||||
|
2015
Q1 | $402K | Sell |
|
|||||
|
2014
Q4 | $744K | Sell |
|
|||||
|
2014
Q3 | $1.81M | Buy |
|
|||||
|
2014
Q2 | $278K | Buy |
|